𝔖 Bobbio Scriptorium
✦   LIBER   ✦

T cell killing of human colon carcinomas by monoclonal-antibody-targeted superantigens

✍ Scribed by Peter A. Lando; Mikael Dohlsten; Gunnar Hedlund; Eva Åkerblom; Terje Kalland

Publisher
Springer-Verlag
Year
1993
Tongue
English
Weight
619 KB
Volume
36
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lymphokine-activated killer cell cytotox
Lymphokine-activated killer cell cytotoxicity against human colon carcinomas enhanced by monoclonal antibody D612
✍ Tribhuvan K. Pendurthi; Ricardo Parker; Jeffrey Schlom; F. James Primus 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 French ⚖ 895 KB

The antibody-dependent cellular cytotoxicity (ADCC) properties of a murine monoclonal antibody (MAb), designated D6l2 (lgG,J, which reacts with human colon carcinomas, was studied using normal human peripheral blood lymphocytes (PBMNC). Although the level of ADCC of PBMNC with D612 varied among diff

Antigenic modulation and internalization
Antigenic modulation and internalization of monoclonal antibody to human colonic carcinoma cells detected by enzyme-linked immunosorbent assay
✍ T. Yokota; E. Otsuji; A. Noguchi; T. Yamaguchi; K. Sawai; T. Takahashi 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 French ⚖ 460 KB

We studied antigenic modulation and internalization of monoclonal antibody (MAb) A7 using the enzyme-linked immunosorbent assay (ELISA) and biotin-labelled antibodystaining techniques. Incubation of the colonic SWI I 16 cell line with an excess of MAb A7 induced modulation of the cellsurface antigen

Inhibition of bispecific monoclonal anti
Inhibition of bispecific monoclonal antibody (bsAb)-targeted cytolysis by human anti-mouse antibodies in ovarian carcinoma patients treated with bsAb-targeted activated T-lymphocytes
✍ Cor H. J. Lamers; Jan W. Gratama; Sven O. Warnaar; Gerrit Stoter; Reinder L. H. 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 743 KB

T lymphocytes of 8 patients with ovarian cancer were targeted to the tumor cells using F(ab')2 fragments of a bispecific monoclonal antibody (bsAb), specific for CD3 (a component of the T lymphocyte receptor for antigen) and for the folate receptor MOv I 8 (overexpressed by ovarian carcinoma cells)